Product
ABC/DTG/3TC immediate release
1 clinical trial
1 indication
Indication
HIV InfectionsClinical trial
Open-label Access to Dolutegravir for HIV-1 Infected Children and Adolescents Completing IMPAACT Studies P1093 and P2019Status: Active (not recruiting), Estimated PCD: 2024-07-31